Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.13 trillion and total revenue of $112.81 billion.
Market Cap
1.13T
Revenue
112.81B
Profits
-38.91B
PE Ratio
n/a
Profit Margin
-34.49%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.87B | -0.62% | 1,112,234 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.14B | -1.66% | 774,510 | 14.92B |
| 3 | ARGX | argenx SE | 49.13B | -2.51% | 580,465 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.51B | -2.34% | 1,143,976 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 35.24B | 1.17% | 441,187 | 5.74B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.30B | -5.67% | 3,174,399 | - |
| 7 | RPRX | Royalty Pharma plc | 29.76B | -1.03% | 5,602,076 | 2.44B |
| 8 | BNTX | BioNTech SE | 23.52B | -2.35% | 574,775 | 3.23B |
| 9 | INSM | Insmed Incorporated | 22.66B | -23.41% | 13,713,239 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 20.24B | -1.87% | 3,545,833 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.53B | -2.08% | 1,021,626 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.26B | -0.51% | 8,476,289 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.00B | -2.98% | 3,497,913 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.21B | 4.34% | 1,491,354 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.24B | -0.70% | 1,129,351 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.31B | -3.92% | 2,720,985 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.21B | -0.94% | 2,866,050 | 502.08M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.56B | -1.08% | 1,885,689 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.33B | -0.90% | 384,447 | 1.13B |
| 20 | EXEL | Exelixis, Inc. | 11.74B | -5.11% | 3,518,854 | 2.38B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.33B | -1.08% | 919,075 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.92B | -1.50% | 2,337,155 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | -0.88% | 2,112,080 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 10.04B | -1.49% | 781,280 | 5.37M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.28B | -1.42% | 457,694 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.24B | -0.73% | 8,400,732 | 105.82M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.75B | 2.67% | 602,050 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 8.09B | -1.76% | 593,730 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.01B | -7.40% | 10,809,517 | 140.98M |
| 30 | TECH | Bio-Techne Corporation | 7.97B | 7.39% | 5,147,216 | 1.21B |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.72B | -1.75% | 1,517,207 | 1.40B |
| 32 | PCVX | Vaxcyte, Inc. | 7.43B | -9.84% | 5,346,416 | - |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.96B | -1.89% | 637,459 | 51.48M |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.59B | -0.39% | 818,342 | 217.17M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.36B | -4.92% | 836,845 | 74.06M |
| 36 | TGTX | TG Therapeutics, Inc. | 6.35B | 2.51% | 3,820,801 | 700.35M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.35B | 0.14% | 923,540 | - |
| 38 | CELC | Celcuity Inc. | 6.32B | -6.26% | 881,309 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | -6.50% | 1,985,101 | 569.61M |
| 40 | BLTE | Belite Bio, Inc | 6.14B | -0.13% | 136,694 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.03% | 1,723,932 | 15.00M |
| 42 | APGE | Apogee Therapeutics, Inc. | 6.11B | -3.23% | 376,647 | - |
| 43 | CGON | CG Oncology, Inc. | 6.09B | 1.72% | 854,523 | 4.04M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.95B | -3.01% | 1,997,793 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 5.61B | 3.71% | 3,370,750 | 907.29M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.54B | -1.40% | 1,888,558 | - |
| 47 | IMVT | Immunovant, Inc. | 5.54B | -5.06% | 1,238,741 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.48B | -2.11% | 1,117,003 | 769.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | -4.42% | 576,359 | 7.50M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.35B | -3.12% | 895,260 | 1.73B |
| 51 | LEGN | Legend Biotech Corporation | 5.28B | -1.35% | 1,357,867 | 1.03B |
| 52 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.27% | 8,392,531 | 1.11B |
| 53 | CRSP | CRISPR Therapeutics AG | 5.06B | -4.83% | 1,516,581 | 4.10M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.67B | -5.47% | 990,143 | 1.34M |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.55B | 4.27% | 1,722,599 | 7.70M |
| 56 | MANE | Veradermics, Incorporated | 4.44B | -1.75% | 592,227 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.21B | -9.55% | 644,041 | 274.48M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 4.01B | 12.46% | 2,500,274 | 22.50M |
| 59 | TVTX | Travere Therapeutics, Inc. | 3.97B | -4.69% | 9,646,980 | 536.20M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.86B | 5.03% | 3,670,072 | 1.10B |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.84B | -8.20% | 3,023,616 | - |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.83B | -3.81% | 1,047,361 | - |
| 63 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 2.11% | 13,635,279 | 588.99M |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.71B | -4.05% | 138,011 | 803.79M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.67B | -2.17% | 1,926,438 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.39B | -0.59% | 6,971,742 | 62.38M |
| 67 | ERAS | Erasca, Inc. | 3.23B | -4.59% | 4,563,267 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 3.15B | -2.69% | 1,755,313 | 164.01M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.13B | -3.43% | 684,096 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.12B | -4.69% | 893,070 | 236.00M |
| 71 | ALMS | Alumis Inc. | 3.02B | -6.82% | 923,819 | 24.05M |
| 72 | KLRA | Kailera Therapeutics, Inc. | 2.91B | -9.03% | 279,786 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.90B | -6.90% | 1,691,227 | - |
| 74 | NKTR | Nektar Therapeutics | 2.81B | -2.02% | 764,243 | 55.23M |
| 75 | GPCR | Structure Therapeutics Inc. | 2.78B | -4.14% | 982,829 | - |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | -1.24% | 1,567,842 | 535.08M |
| 77 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.02% | 1,982,269 | 190.41M |
| 78 | KOD | Kodiak Sciences Inc. | 2.71B | -4.82% | 367,619 | - |
| 79 | CLDX | Celldex Therapeutics, Inc. | 2.61B | -3.11% | 508,436 | 1.55M |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 2.58B | -14.52% | 6,822,559 | 415.62M |
| 81 | IRON | Disc Medicine, Inc. | 2.58B | -1.63% | 395,188 | - |
| 82 | VERA | Vera Therapeutics, Inc. | 2.57B | -1.95% | 972,542 | - |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | 0.77% | 1,978,478 | 670.00M |
| 84 | DFTX | Definium Therapeutics, Inc. | 2.53B | -0.94% | 1,752,464 | - |
| 85 | IMNM | Immunome, Inc. | 2.51B | -4.64% | 462,529 | 6.94M |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -1.74% | 947,750 | 225.27M |
| 87 | ELVN | Enliven Therapeutics, Inc. | 2.45B | -2.21% | 291,657 | - |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.42B | -2.56% | 1,701,982 | - |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.40B | -3.17% | 3,211,246 | 10.68M |
| 90 | ZLAB | Zai Lab Limited | 2.22B | -5.93% | 1,268,513 | 460.16M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -9.68% | 5,140,254 | 2.18B |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -0.31% | 1,098,044 | 52.04M |
| 93 | AAPG | Ascentage Pharma Group International | 2.06B | 0.60% | 1,984 | 82.08M |
| 94 | NBTX | Nanobiotix S.A. | 2.05B | 2.08% | 119,331 | 38.27M |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.04B | -1.47% | 334,683 | 184.42M |
| 96 | TRVI | Trevi Therapeutics, Inc. | 1.99B | -1.47% | 2,118,862 | - |
| 97 | ADMA | ADMA Biologics, Inc. | 1.97B | -15.97% | 17,642,522 | 509.86M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -6.80% | 2,795,563 | 298.30M |
| 99 | CAPR | Capricor Therapeutics, Inc. | 1.96B | -1.28% | 564,446 | 11.13M |
| 100 | MESO | Mesoblast Limited | 1.96B | -6.39% | 201,735 | 65.38M |
| 101 | ZYME | Zymeworks Inc. | 1.96B | -3.66% | 707,858 | 105.97M |
| 102 | TYRA | Tyra Biosciences, Inc. | 1.96B | -2.66% | 356,157 | - |
| 103 | SION | Sionna Therapeutics, Inc. | 1.96B | 0.05% | 777,420 | - |
| 104 | PHVS | Pharvaris N.V. | 1.94B | -1.73% | 213,772 | - |
| 105 | ANAB | AnaptysBio, Inc. | 1.92B | -0.59% | 1,390,621 | 234.60M |
| 106 | TSHA | Taysha Gene Therapies, Inc. | 1.92B | -4.44% | 2,782,374 | 7.47M |
| 107 | NTLA | Intellia Therapeutics, Inc. | 1.92B | -1.01% | 4,033,286 | 67.67M |
| 108 | RAPP | Rapport Therapeutics, Inc. | 1.91B | 7.74% | 997,412 | 20.00M |
| 109 | OCS | Oculis Holding AG | 1.84B | 5.10% | 569,488 | 1.51M |
| 110 | GLPG | Galapagos NV | 1.83B | -3.75% | 288,095 | 1.20B |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -0.53% | 1,187,909 | 217.17M |
| 112 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -12.21% | 465,035 | 1.30M |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | -4.15% | 2,229,891 | 899.11M |
| 114 | VCEL | Vericel Corporation | 1.79B | -4.49% | 1,192,575 | 292.09M |
| 115 | VRDN | Viridian Therapeutics, Inc. | 1.75B | -3.02% | 11,273,088 | 70.92M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.73B | -11.21% | 318,023 | 31.89M |
| 117 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -4.66% | 12,001,181 | 66.41M |
| 118 | ARDX | Ardelyx, Inc. | 1.72B | -1.69% | 3,920,940 | 427.68M |
| 119 | INVA | Innoviva, Inc. | 1.68B | 0.98% | 1,126,740 | 420.69M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.68B | -3.64% | 663,080 | 71.78M |
| 121 | NUVB | Nuvation Bio Inc. | 1.67B | -4.56% | 4,428,742 | 143.05M |
| 122 | MBX | MBX Biosciences, Inc. | 1.65B | 8.06% | 928,267 | - |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 2.04% | 722,493 | 66.05M |
| 124 | PVLA | Palvella Therapeutics, Inc. | 1.62B | -12.99% | 571,436 | - |
| 125 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | -2.84% | 661,133 | 42.95M |
| 126 | IMCR | Immunocore Holdings plc | 1.56B | -0.36% | 358,192 | 412.81M |
| 127 | QURE | uniQure N.V. | 1.52B | 5.83% | 1,941,506 | 18.09M |
| 128 | NVAX | Novavax, Inc. | 1.52B | -1.39% | 9,162,762 | 596.34M |
| 129 | BCAX | Bicara Therapeutics Inc. | 1.51B | -2.90% | 345,249 | - |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.51B | 1.22% | 1,874,369 | - |
| 131 | VIR | Vir Biotechnology, Inc. | 1.49B | -9.91% | 2,787,903 | 65.50M |
| 132 | IMTX | Immatics N.V. | 1.49B | -3.21% | 735,713 | 56.67M |
| 133 | FTRE | Fortrea Holdings Inc. | 1.47B | -0.45% | 1,631,239 | 2.71B |
| 134 | ATAI | AtaiBeckley Inc. | 1.47B | -3.84% | 4,325,350 | 4.09M |
| 135 | PGEN | Precigen, Inc. | 1.47B | -5.68% | 3,096,739 | 9.68M |
| 136 | BHVN | Biohaven Ltd. | 1.47B | -2.99% | 1,261,071 | - |
| 137 | IOVA | Iovance Biotherapeutics, Inc. | 1.46B | -13.20% | 39,908,058 | 285.61M |
| 138 | ABCL | AbCellera Biologics Inc. | 1.46B | -4.37% | 11,261,567 | 75.13M |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.78% | 468,614 | 2.50M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.39B | -0.69% | 4,208,420 | 71.80M |
| 141 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | - | 1,330,763 | 73.62M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -2.60% | 209,043 | - |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 0.55% | 210,434 | - |
| 144 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | -0.39% | 1,222,924 | - |
| 145 | SVRA | Savara Inc. | 1.31B | -1.99% | 938,268 | - |
| 146 | GHRS | GH Research PLC | 1.30B | -6.37% | 198,490 | - |
| 147 | URGN | UroGen Pharma Ltd. | 1.30B | 1.30% | 1,338,194 | 140.49M |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.23B | -2.82% | 765,267 | - |
| 149 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | -5.57% | 1,350,352 | - |
| 150 | JBIO | Jade Biosciences, Inc. | 1.20B | -3.62% | 380,696 | - |
| 151 | DBVT | DBV Technologies S.A. | 1.17B | -0.60% | 108,082 | 5.74M |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.15B | -7.49% | 448,451 | 10.00M |
| 153 | COAG | Hemab Therapeutics Holdings, Inc. | 1.14B | 2.92% | 202,109 | - |
| 154 | AVLN | Avalyn Pharma Inc. | 1.13B | -2.62% | 664,374 | - |
| 155 | EYPT | EyePoint, Inc. | 1.12B | 0.45% | 1,122,334 | 7.61M |
| 156 | IVA | Inventiva S.A. | 1.10B | -0.74% | 374,110 | 7.94M |
| 157 | MNKD | MannKind Corporation | 1.10B | -0.28% | 7,653,088 | 360.78M |
| 158 | SEPN | Septerna, Inc. | 1.08B | -2.95% | 218,326 | 45.95M |
| 159 | OMER | Omeros Corporation | 1.05B | -1.28% | 635,710 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 1.04B | -5.92% | 171,505 | 6.50M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.02B | - | 4,831,007 | 185.74M |
| 162 | PHAT | Phathom Pharmaceuticals, Inc. | 971.43M | -3.47% | 808,490 | 204.89M |
| 163 | SANA | Sana Biotechnology, Inc. | 971.25M | -3.85% | 2,137,178 | - |
| 164 | GERN | Geron Corporation | 935.71M | -7.59% | 17,369,534 | 196.12M |
| 165 | LBRX | LB Pharmaceuticals Inc | 917.05M | -0.06% | 85,753 | - |
| 166 | XNCR | Xencor, Inc. | 912.51M | -5.38% | 947,693 | 97.36M |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 911.99M | -5.27% | 1,343,811 | - |
| 168 | SLS | SELLAS Life Sciences Group, Inc. | 909.75M | -4.27% | 2,221,970 | - |
| 169 | CGEM | Cullinan Therapeutics, Inc. | 904.56M | -1.80% | 1,227,571 | - |
| 170 | ANNX | Annexon, Inc. | 897.04M | -3.16% | 2,357,564 | - |
| 171 | MGTX | MeiraGTx Holdings plc | 895.03M | -2.32% | 435,679 | 81.39M |
| 172 | ABSI | Absci Corporation | 893.82M | -3.36% | 6,465,596 | 2.80M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 893.68M | -3.02% | 1,479,809 | 84.28M |
| 174 | JANX | Janux Therapeutics, Inc. | 886.38M | -0.55% | 622,935 | 10.00M |
| 175 | DSGN | Design Therapeutics, Inc. | 880.64M | -3.09% | 394,077 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 876.78M | 0.47% | 346,753 | 109.78M |
| 177 | DRUG | Bright Minds Biosciences Inc. | 874.60M | -0.10% | 140,145 | - |
| 178 | VOR | Vor Biopharma Inc. | 871.31M | 1.13% | 750,220 | - |
| 179 | CTMX | CytomX Therapeutics, Inc. | 870.78M | -3.15% | 3,097,083 | 76.20M |
| 180 | PHAR | Pharming Group N.V. | 860.79M | -26.83% | 96,019 | 369.49M |
| 181 | ABUS | Arbutus Biopharma Corporation | 856.69M | -1.58% | 923,760 | 14.08M |
| 182 | SGP | SpyGlass Pharma, Inc. | 847.53M | 1.20% | 134,541 | - |
| 183 | ANRO | Alto Neuroscience, Inc. | 843.72M | -1.71% | 614,811 | - |
| 184 | KURA | Kura Oncology, Inc. | 827.27M | -2.51% | 947,506 | 67.48M |
| 185 | SPTX | Seaport Therapeutics, Inc. | 824.58M | -2.81% | 429,722 | - |
| 186 | EVMN | Evommune, Inc. | 810.41M | -5.58% | 289,021 | 13.00M |
| 187 | ALLO | Allogene Therapeutics, Inc. | 780.83M | -1.73% | 5,675,084 | 22.00K |
| 188 | RLMD | Relmada Therapeutics, Inc. | 779.32M | -5.47% | 679,817 | - |
| 189 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | 5.00% | 5,024,106 | 49.80M |
| 190 | SLDB | Solid Biosciences Inc. | 695.78M | -1.81% | 752,668 | - |
| 191 | DRTS | Alpha Tau Medical Ltd. | 690.88M | 3.43% | 508,777 | - |
| 192 | TENX | Tenax Therapeutics, Inc. | 685.93M | -3.08% | 888,565 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 685.75M | -12.06% | 96,958 | 117.05M |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 678.77M | 1.67% | 1,135,662 | 8.37M |
| 195 | STRO | Sutro Biopharma, Inc. | 659.90M | 5.68% | 258,046 | 102.48M |
| 196 | CABA | Cabaletta Bio, Inc. | 652.20M | 7.24% | 4,731,242 | - |
| 197 | ARVN | Arvinas, Inc. | 651.76M | -0.68% | 784,308 | 262.60M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 650.26M | -2.22% | 2,436,103 | 122.29M |
| 199 | FBRX | Forte Biosciences, Inc. | 640.59M | -1.32% | 120,662 | - |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 629.06M | -5.64% | 374,544 | - |
| 201 | CRMD | CorMedix Inc. | 621.15M | -1.61% | 892,393 | 311.71M |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 619.22M | -12.00% | 542,434 | - |
| 203 | AVTX | Avalo Therapeutics, Inc. | 610.96M | 4.86% | 5,741,760 | 59.00K |
| 204 | DNA | Ginkgo Bioworks Holdings, Inc. | 600.70M | 2.38% | 1,856,333 | 170.16M |
| 205 | CBIO | Crescent Biopharma, Inc. | 598.29M | -0.30% | 77,632 | 11.88M |
| 206 | ALT | Altimmune, Inc. | 590.37M | -6.75% | 3,715,779 | 41.00K |
| 207 | CADL | Candel Therapeutics, Inc. | 570.59M | 2.10% | 2,326,929 | - |
| 208 | CLYM | Climb Bio, Inc. | 568.92M | -2.54% | 929,950 | - |
| 209 | PROK | ProKidney Corp. | 567.69M | -4.08% | 847,390 | 893.00K |
| 210 | PRTA | Prothena Corporation plc | 566.32M | -5.90% | 443,068 | 9.68M |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 562.93M | -1.80% | 431,084 | - |
| 212 | AGMB | AgomAb Therapeutics NV | 562.41M | -6.70% | 71,147 | - |
| 213 | PRME | Prime Medicine, Inc. | 551.80M | -8.65% | 3,750,255 | 4.03M |
| 214 | MDXG | MiMedx Group, Inc. | 549.61M | 0.82% | 1,529,570 | 389.42M |
| 215 | ANL | Adlai Nortye Ltd. | 548.00M | -3.99% | 183,506 | 5.00M |
| 216 | VALN | Valneva SE | 546.89M | 4.07% | 37,974 | 205.07M |
| 217 | CTNM | Contineum Therapeutics, Inc. | 546.23M | -2.07% | 171,484 | - |
| 218 | RGNX | REGENXBIO Inc. | 537.85M | 1.96% | 1,467,286 | 170.44M |
| 219 | AURA | Aura Biosciences, Inc. | 526.44M | -1.09% | 404,746 | - |
| 220 | FDMT | 4D Molecular Therapeutics, Inc. | 519.09M | -4.70% | 737,281 | 85.21M |
| 221 | PRLD | Prelude Therapeutics Incorporated | 517.85M | 6.40% | 546,593 | 12.14M |
| 222 | TECX | Tectonic Therapeutic, Inc. | 506.46M | -7.41% | 242,009 | - |
| 223 | IMMX | Immix Biopharma, Inc. | 505.74M | -7.56% | 649,083 | - |
| 224 | VSTM | Verastem, Inc. | 497.19M | -5.82% | 1,620,548 | 30.91M |
| 225 | EIKN | Eikon Therapeutics, Inc. | 496.45M | -8.02% | 238,783 | - |
| 226 | XOMA | XOMA Royalty Corporation | 492.00M | -0.75% | 194,875 | 52.15M |
| 227 | ASMB | Assembly Biosciences, Inc. | 491.56M | -1.37% | 163,651 | 72.30M |
| 228 | UPB | Upstream Bio, Inc. | 488.96M | -2.23% | 272,835 | 2.85M |
| 229 | NGNE | Neurogene Inc. | 488.15M | -3.31% | 152,687 | 925.00K |
| 230 | OCGN | Ocugen, Inc. | 487.46M | -1.03% | 5,151,941 | 4.47M |
| 231 | RIGL | Rigel Pharmaceuticals, Inc. | 485.49M | -1.61% | 349,691 | 299.77M |
| 232 | ADCT | ADC Therapeutics SA | 476.97M | -2.85% | 1,408,360 | 79.18M |
| 233 | STTK | Shattuck Labs, Inc. | 473.14M | -6.29% | 695,663 | 1.00M |
| 234 | OVID | Ovid Therapeutics Inc. | 472.39M | -1.80% | 1,379,536 | 7.25M |
| 235 | SGMT | Sagimet Biosciences Inc. | 471.78M | -8.83% | 1,024,845 | - |
| 236 | LYEL | Lyell Immunopharma, Inc. | 468.05M | -3.79% | 52,199 | 31.00K |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 462.22M | -1.45% | 127,097 | - |
| 238 | FULC | Fulcrum Therapeutics, Inc. | 458.44M | -3.23% | 459,330 | 80.00M |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 443.35M | -1.95% | 192,201 | - |
| 240 | ENTA | Enanta Pharmaceuticals, Inc. | 437.90M | -0.98% | 196,473 | 66.98M |
| 241 | LXEO | Lexeo Therapeutics, Inc. | 431.19M | -6.58% | 571,920 | - |
| 242 | ZURA | Zura Bio Limited | 430.76M | -7.16% | 976,506 | - |
| 243 | AUTL | Autolus Therapeutics plc | 428.49M | -5.29% | 1,272,810 | 75.39M |
| 244 | PRTC | PureTech Health plc | 424.14M | -0.21% | 39,997 | 4.66M |
| 245 | MNPR | Monopar Therapeutics Inc. | 417.79M | -2.24% | 198,348 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 416.62M | -1.28% | 759,334 | 109.16M |
| 247 | BNTC | Benitec Biopharma Inc. | 415.85M | -3.42% | 60,819 | - |
| 248 | LRMR | Larimar Therapeutics, Inc. | 415.53M | -3.61% | 1,557,166 | - |
| 249 | IVVD | Invivyd, Inc. | 404.41M | -2.05% | 2,143,019 | 53.43M |
| 250 | RCKT | Rocket Pharmaceuticals, Inc. | 400.67M | -4.92% | 2,097,168 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 390.05M | -2.05% | 329,833 | 9.01M |
| 252 | VTVT | vTv Therapeutics Inc. | 385.19M | -2.02% | 33,759 | 17.00K |
| 253 | VNDA | Vanda Pharmaceuticals Inc. | 384.26M | -14.11% | 1,205,542 | 217.78M |
| 254 | IRD | Opus Genetics, Inc. | 382.72M | 1.90% | 1,168,103 | 14.20M |
| 255 | YDES | YD Bio Limited | 372.10M | 1.88% | 1,166 | 510.36K |
| 256 | PBYI | Puma Biotechnology, Inc. | 369.47M | -2.55% | 352,271 | 228.37M |
| 257 | NAUT | Nautilus Biotechnology, Inc. | 365.99M | -2.04% | 169,489 | - |
| 258 | NMRA | Neumora Therapeutics, Inc. | 354.41M | -16.74% | 2,682,803 | - |
| 259 | SRZN | Surrozen, Inc. | 353.22M | -9.90% | 77,115 | 7.49M |
| 260 | DMAC | DiaMedica Therapeutics Inc. | 351.31M | - | 304,830 | - |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 341.25M | -4.20% | 1,504,333 | 14.56M |
| 262 | BCYC | Bicycle Therapeutics plc | 340.87M | -5.05% | 417,571 | 63.50M |
| 263 | IKT | Inhibikase Therapeutics, Inc. | 339.20M | -1.00% | 796,476 | 1.00 |
| 264 | IMRX | Immuneering Corporation | 337.72M | 0.58% | 558,143 | - |
| 265 | NAGE | Niagen Bioscience, Inc. | 336.24M | -15.69% | 863,509 | 130.42M |
| 266 | ARMP | Armata Pharmaceuticals, Inc. | 335.76M | 0.99% | 110,681 | 4.90M |
| 267 | PALI | Palisade Bio, Inc. | 333.17M | -0.50% | 3,885,523 | - |
| 268 | SLN | Silence Therapeutics plc | 328.28M | -5.57% | 136,222 | 559.00K |
| 269 | ABEO | Abeona Therapeutics Inc. | 328.21M | -3.99% | 1,498,986 | 5.82M |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 327.24M | 2.43% | 47,310 | - |
| 271 | CMPX | Compass Therapeutics, Inc. | 325.96M | -3.21% | 5,753,063 | 850.00K |
| 272 | RZLT | Rezolute, Inc. | 320.96M | -1.59% | 932,917 | - |
| 273 | NGEN | NervGen Pharma Corp. | 311.58M | -1.03% | 102,476 | - |
| 274 | ARTV | Artiva Biotherapeutics, Inc. | 309.45M | 1.05% | 151,704 | 251.00K |
| 275 | LENZ | LENZ Therapeutics, Inc. | 304.76M | 0.41% | 564,965 | 19.09M |
| 276 | ZNTL | Zentalis Pharmaceuticals, Inc. | 300.04M | 1.20% | 656,249 | 26.87M |
| 277 | EDIT | Editas Medicine, Inc. | 296.66M | -4.57% | 1,439,800 | 38.69M |
| 278 | TARA | Protara Therapeutics, Inc. | 295.67M | -5.12% | 440,311 | - |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 293.23M | 1.58% | 1,226,532 | - |
| 280 | CCCC | C4 Therapeutics, Inc. | 290.78M | 1.71% | 2,796,398 | 35.95M |
| 281 | ACIU | AC Immune SA | 289.67M | -1.68% | 200,407 | 4.62M |
| 282 | AVXL | Anavex Life Sciences Corp. | 289.14M | -6.59% | 1,190,834 | - |
| 283 | SABS | SAB Biotherapeutics, Inc. | 287.43M | 7.63% | 3,277,800 | 114.70K |
| 284 | CLLS | Cellectis S.A. | 282.89M | -3.29% | 12,017 | 79.59M |
| 285 | FATE | Fate Therapeutics, Inc. | 282.56M | 6.11% | 4,380,647 | 6.65M |
| 286 | REPL | Replimune Group, Inc. | 275.79M | -2.91% | 2,432,029 | - |
| 287 | NVCT | Nuvectis Pharma, Inc. | 273.74M | 3.20% | 96,970 | - |
| 288 | CHRS | Coherus Oncology, Inc. | 271.42M | 0.57% | 920,187 | 42.17M |
| 289 | ALEC | Alector, Inc. | 270.90M | -5.06% | 163,899 | 21.05M |
| 290 | CGEN | Compugen Ltd. | 270.42M | 3.62% | 387,142 | 72.76M |
| 291 | NERV | Minerva Neurosciences, Inc. | 269.19M | -1.44% | 71,913 | - |
| 292 | HELP | Cybin Inc. | 267.19M | -3.61% | 595,715 | - |
| 293 | NBP | NovaBridge Biosciences | 256.74M | -1.33% | 693,102 | - |
| 294 | ACHV | Achieve Life Sciences, Inc. | 255.02M | -0.21% | 759,977 | - |
| 295 | ARCT | Arcturus Therapeutics Holdings Inc. | 252.97M | -2.52% | 206,238 | 82.03M |
| 296 | ALXO | ALX Oncology Holdings Inc. | 251.63M | -10.53% | 632,508 | - |
| 297 | TRDA | Entrada Therapeutics, Inc. | 250.27M | -57.27% | 4,118,207 | 5.74M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 246.54M | -10.26% | 206,141 | 28.22M |
| 299 | FENC | Fennec Pharmaceuticals Inc. | 239.87M | -3.76% | 207,025 | 44.64M |
| 300 | HUMA | Humacyte, Inc. | 239.78M | 9.83% | 9,354,395 | 2.04M |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 239.75M | -2.16% | 180,996 | 1.78M |
| 302 | VYGR | Voyager Therapeutics, Inc. | 239.25M | -5.04% | 250,205 | 40.37M |
| 303 | ADAG | Adagene Inc. | 236.54M | -0.83% | 68,208 | 7.67M |
| 304 | CDXS | Codexis, Inc. | 234.51M | -3.01% | 1,688,885 | 70.39M |
| 305 | HRTX | Heron Therapeutics, Inc. | 233.91M | -5.34% | 1,344,670 | 154.90M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 231.81M | -4.06% | 621,870 | 1.55M |
| 307 | KROS | Keros Therapeutics, Inc. | 230.33M | -1.19% | 157,107 | 244.06M |
| 308 | OBIO | Orchestra BioMed Holdings, Inc. | 229.99M | -4.38% | 145,731 | 33.48M |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 228.83M | -1.96% | 9,041 | 19.39M |
| 310 | CAMP | Camp4 Therapeutics Corporation | 225.36M | 6.90% | 45,425 | 3.50M |
| 311 | NKTX | Nkarta, Inc. | 224.57M | -5.12% | 1,028,890 | - |
| 312 | MDWD | MediWound Ltd. | 221.96M | -0.58% | 140,814 | 16.96M |
| 313 | CNTX | Context Therapeutics Inc. | 214.08M | -3.32% | 351,084 | - |
| 314 | OABI | OmniAb, Inc. | 212.83M | 2.80% | 360,214 | 18.67M |
| 315 | RNA | Atrium Therapeutics, Inc. | 201.07M | -0.99% | 91,236 | 18.62M |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 199.51M | -1.88% | 168,888 | 146.07M |
| 317 | UNCY | Unicycive Therapeutics, Inc. | 198.37M | -3.32% | 745,151 | - |
| 318 | WHWK | Whitehawk Therapeutics, Inc. | 194.75M | -5.06% | 136,387 | 7.15M |
| 319 | ENLV | Enlivex Ltd. | 193.59M | -3.59% | 190,163 | - |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.48M | -7.28% | 453,674 | 13.11M |
| 321 | DTIL | Precision BioSciences, Inc. | 193.01M | -0.53% | 152,207 | 45.07M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 192.80M | -0.46% | 274,658 | - |
| 323 | TLSA | Tiziana Life Sciences Ltd | 192.71M | 2.72% | 81,461 | - |
| 324 | IFRX | InflaRx N.V. | 191.58M | 6.00% | 8,829,337 | 33.82K |
| 325 | MGNX | MacroGenics, Inc. | 186.87M | -2.33% | 499,732 | 149.50M |
| 326 | KRRO | Korro Bio, Inc. | 185.91M | -3.37% | 99,212 | 3.84M |
| 327 | CRBU | Caribou Biosciences, Inc. | 184.73M | -3.59% | 1,666,512 | 11.16M |
| 328 | ELTX | Elicio Therapeutics, Inc. | 184.14M | -4.21% | 137,495 | - |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 184.10M | 7.37% | 2,245,958 | 225.00K |
| 330 | PLYX | Polaryx Therapeutics, Inc. | 180.85M | 0.53% | 130,836 | - |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 178.40M | -3.89% | 328,304 | - |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 168.84M | -6.88% | 651,552 | - |
| 333 | PRQR | ProQR Therapeutics N.V. | 166.47M | -8.14% | 538,608 | 19.19M |
| 334 | ANTX | AN2 Therapeutics, Inc. | 165.94M | -0.86% | 149,320 | - |
| 335 | NTHI | NeOnc Technologies Holdings, Inc. | 163.48M | 22.22% | 228,892 | 39.99K |
| 336 | OKUR | OnKure Therapeutics, Inc. | 159.97M | -2.70% | 93,788 | - |
| 337 | IMUX | Immunic, Inc. | 159.80M | 6.62% | 359,798 | - |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 159.53M | -1.98% | 1,583,475 | 52.74M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 158.55M | - | 103,157 | 2.00M |
| 340 | MENS | Jyong Biotech Ltd. | 157.65M | -4.65% | 41,489 | - |
| 341 | MOLN | Molecular Partners AG | 157.48M | -4.33% | 4,102 | 856.30K |
| 342 | BDTX | Black Diamond Therapeutics, Inc. | 155.83M | -3.55% | 1,243,365 | 70.00M |
| 343 | EDSA | Edesa Biotech, Inc. | 154.88M | 16.28% | 479,454 | - |
| 344 | KZIA | Kazia Therapeutics Limited | 153.23M | -3.11% | 59,127 | 1.27M |
| 345 | SPRB | Spruce Biosciences, Inc. | 152.87M | -2.25% | 21,357 | 697.00K |
| 346 | HURA | TuHURA Biosciences, Inc. | 152.59M | -5.51% | 561,537 | - |
| 347 | SPRO | Spero Therapeutics, Inc. | 145.33M | -0.79% | 547,986 | 66.80M |
| 348 | AGEN | Agenus Inc. | 143.99M | -3.60% | 1,054,486 | 114.20M |
| 349 | PYXS | Pyxis Oncology, Inc. | 142.00M | -1.74% | 718,972 | 13.86M |
| 350 | VRCA | Verrica Pharmaceuticals Inc. | 140.35M | -3.08% | 102,787 | 35.58M |
| 351 | IPHA | Innate Pharma S.A. | 139.82M | -9.27% | 29,097 | 10.57M |
| 352 | GALT | Galectin Therapeutics Inc. | 138.90M | -6.22% | 501,145 | - |
| 353 | ALPS | Alps Group Inc | 138.77M | 1.34% | 10,903 | 3.74M |
| 354 | EQ | Equillium, Inc. | 135.30M | -1.38% | 88,173 | 4.39M |
| 355 | ACOG | Alpha Cognition Inc. | 132.60M | -4.55% | 5,359 | 10.22M |
| 356 | CNTB | Connect Biopharma Holdings Limited | 131.69M | -6.05% | 127,506 | 64.00K |
| 357 | GNLX | Genelux Corporation | 125.57M | -1.39% | 188,606 | 8.00K |
| 358 | PEPG | PepGen Inc. | 123.81M | -2.98% | 413,217 | - |
| 359 | AARD | Aardvark Therapeutics, Inc. | 122.17M | -4.92% | 126,182 | - |
| 360 | GUTS | Fractyl Health, Inc. | 118.69M | 1.75% | 1,797,267 | 3.00K |
| 361 | KLRS | Kalaris Therapeutics, Inc. | 118.41M | 1.78% | 103,150 | - |
| 362 | BMEA | Biomea Fusion, Inc. | 117.85M | 1.87% | 986,400 | - |
| 363 | CUE | Cue Biopharma, Inc. | 116.31M | 5.15% | 426,714 | 27.47M |
| 364 | ENGN | enGene Therapeutics Inc. | 115.22M | -80.56% | 23,934,112 | - |
| 365 | CBUS | Cibus, Inc. | 114.42M | -5.66% | 299,866 | 3.64M |
| 366 | TTRX | Turn Therapeutics Inc. | 113.05M | - | 3,115 | - |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 112.25M | 10.48% | 3,680,684 | 65.34K |
| 368 | CRDF | Cardiff Oncology, Inc. | 109.39M | -4.76% | 447,176 | 593.00K |
| 369 | SEER | Seer, Inc. | 106.35M | -0.26% | 154,359 | 16.58M |
| 370 | ONCY | Oncolytics Biotech Inc. | 104.52M | -2.17% | 845,169 | - |
| 371 | ALDX | Aldeyra Therapeutics, Inc. | 104.36M | -0.57% | 597,657 | - |
| 372 | CGTX | Cognition Therapeutics, Inc. | 103.65M | -5.69% | 469,629 | - |
| 373 | VANI | Vivani Medical, Inc. | 102.42M | -3.20% | 125,549 | - |
| 374 | NRXS | NeurAxis, Inc. | 101.25M | -0.11% | 152,406 | 3.57M |
| 375 | NRXP | NRx Pharmaceuticals, Inc. | 101.09M | 0.33% | 850,335 | 1.23M |
| 376 | ANIX | Anixa Biosciences, Inc. | 99.24M | -3.27% | 115,581 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 98.52M | -0.94% | 100,851 | 7.95M |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 92.93M | -3.03% | 364,361 | 1.63M |
| 379 | LONA | LeonaBio, Inc. | 92.62M | 4.67% | 39,911 | - |
| 380 | QTTB | Q32 Bio Inc. | 92.24M | -0.55% | 154,777 | 53.74M |
| 381 | RNTX | Rein Therapeutics Inc. | 91.31M | - | 648,385 | - |
| 382 | ATYR | aTyr Pharma, Inc. | 90.38M | -11.37% | 1,211,246 | 190.00K |
| 383 | ACET | Adicet Bio, Inc. | 89.43M | -2.69% | 60,125 | - |
| 384 | PMN | ProMIS Neurosciences, Inc. | 88.15M | -10.64% | 113,870 | - |
| 385 | OKYO | OKYO Pharma Limited | 85.02M | -3.57% | 46,863 | - |
| 386 | EXOZ | eXoZymes, Inc. | 84.79M | -5.12% | 269 | -700.00 |
| 387 | PYPD | PolyPid Ltd. | 84.63M | -1.00% | 14,048 | - |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 84.53M | 92.82% | 76,741,520 | 120.77M |
| 389 | PTHS | Pelthos Therapeutics Inc. | 83.99M | 0.12% | 7,696 | 16.80M |
| 390 | CSBR | Champions Oncology, Inc. | 83.18M | 0.17% | 9,508 | 57.95M |
| 391 | GOSS | Gossamer Bio, Inc. | 80.67M | -1.86% | 2,365,987 | 48.47M |
| 392 | FBIO | Fortress Biotech, Inc. | 79.73M | -5.88% | 245,603 | 63.26M |
| 393 | GANX | Gain Therapeutics, Inc. | 79.55M | -2.36% | 342,983 | - |
| 394 | MAIA | MAIA Biotechnology, Inc. | 79.48M | -2.96% | 268,894 | - |
| 395 | ACTU | Actuate Therapeutics, Inc. | 79.20M | 11.71% | 156,686 | - |
| 396 | ATHE | Alterity Therapeutics Limited | 78.82M | 3.32% | 41,343 | 4.43M |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 78.65M | -2.87% | 453,985 | - |
| 398 | ANVS | Annovis Bio, Inc. | 78.04M | -5.83% | 890,184 | - |
| 399 | RLYB | Rallybio Corporation | 77.55M | 0.69% | 129,829 | 858.00K |
| 400 | KALA | KALA BIO, Inc. | 77.24M | -27.80% | 2,764,701 | - |
| 401 | ICCC | ImmuCell Corporation | 76.81M | -1.96% | 32,099 | 27.64M |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 76.79M | -0.69% | 348,245 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 76.77M | 0.81% | 671,207 | - |
| 404 | XBIT | XBiotech Inc. | 76.22M | -1.96% | 28,236 | - |
| 405 | MCRB | Seres Therapeutics, Inc. | 74.36M | -3.50% | 48,242 | 1.15M |
| 406 | TCRX | TScan Therapeutics, Inc. | 72.72M | -3.20% | 801,829 | 9.14M |
| 407 | OSTX | OS Therapies Incorporated | 71.47M | -1.73% | 459,239 | - |
| 408 | MNOV | MediciNova, Inc. | 70.39M | -1.38% | 6,862 | 409.66K |
| 409 | IBO | Impact BioMedical Inc. | 67.61M | -1.24% | 46,861 | 32.00K |
| 410 | IMA | ImageneBio, Inc. | 66.10M | -2.80% | 100,024 | 800.00K |
| 411 | FLNA | Filana Therapeutics, Inc. | 65.70M | -5.56% | 524,610 | - |
| 412 | CING | Cingulate Inc. | 64.07M | -1.88% | 404,718 | - |
| 413 | ENTX | Entera Bio Ltd. | 63.87M | 9.60% | 104,653 | 42.00K |
| 414 | PDSB | PDS Biotechnology Corporation | 63.63M | 7.55% | 714,162 | - |
| 415 | IMMP | Immutep Limited | 62.92M | -2.26% | 898,986 | 5.28M |
| 416 | HYFT | MindWalk Holdings Corp. | 59.60M | -5.51% | 116,501 | 20.70M |
| 417 | IBIO | iBio, Inc. | 59.28M | -7.34% | 370,897 | 300.00K |
| 418 | BYSI | BeyondSpring Inc. | 58.39M | -8.39% | 16,951 | 1.88M |
| 419 | LIXT | Lixte Biotechnology Holdings, Inc. | 57.28M | 12.05% | 163,074 | - |
| 420 | INKT | MiNK Therapeutics, Inc. | 55.57M | -0.18% | 9,808 | - |
| 421 | TIL | Instil Bio, Inc. | 54.46M | 0.25% | 62,589 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 54.37M | -0.27% | 176,455 | - |
| 423 | ESLA | Estrella Immunopharma, Inc. | 54.18M | -2.31% | 18,027 | - |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 53.46M | -0.70% | 200,027 | 25.21M |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 52.11M | -5.45% | 191,027 | - |
| 426 | ATOS | Atossa Therapeutics, Inc. | 48.83M | -2.24% | 46,534 | - |
| 427 | RADX | Radiopharm Theranostics Limited | 48.81M | -2.35% | 13,906 | 10.86M |
| 428 | XLO | Xilio Therapeutics, Inc. | 46.73M | -1.14% | 6,912 | 43.77M |
| 429 | NTRB | Nutriband Inc. | 45.95M | -4.79% | 10,688 | 2.04M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | -1.49% | 80,778 | - |
| 431 | DARE | Daré Bioscience, Inc. | 42.37M | -7.91% | 746,738 | 1.03M |
| 432 | LITS | Lite Strategy, Inc. | 41.45M | -4.20% | 478,510 | - |
| 433 | PSTV | Plus Therapeutics, Inc. | 40.83M | -0.83% | 109,676 | 5.21M |
| 434 | HYPD | Hyperion DeFi, Inc. | 40.67M | -1.92% | 256,277 | 813.46K |
| 435 | RNXT | RenovoRx, Inc. | 39.65M | -1.10% | 205,465 | 1.12M |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 39.50M | 15.03% | 103,948 | - |
| 437 | MREO | Mereo BioPharma Group plc | 38.31M | 1.18% | 1,423,262 | 500.00K |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 38.03M | -1.61% | 177,563 | 90.00K |
| 439 | INMB | INmune Bio Inc. | 38.02M | -5.92% | 300,065 | 50.00K |
| 440 | ALGS | Aligos Therapeutics, Inc. | 37.31M | -5.34% | 90,065 | 2.19M |
| 441 | PTN | Palatin Technologies, Inc. | 37.00M | -0.53% | 4,994 | 8.96M |
| 442 | NXTC | NextCure, Inc. | 36.72M | -5.04% | 13,794 | - |
| 443 | VERU | Veru Inc. | 36.59M | 2.70% | 22,176 | 16.89M |
| 444 | CRVO | CervoMed Inc. | 35.18M | -0.78% | 81,235 | 4.01M |
| 445 | APLM | Apollomics, Inc. | 34.92M | 4.33% | 4,328 | 8.84M |
| 446 | GRCE | Grace Therapeutics, Inc. | 34.82M | -5.06% | 355,066 | - |
| 447 | BOLD | Boundless Bio, Inc. | 34.75M | -1.90% | 115,945 | - |
| 448 | EVAX | Evaxion A/S | 33.94M | -7.71% | 12,217 | 7.53M |
| 449 | PLUR | Pluri Inc. | 33.57M | 1.21% | 1,933 | 1.34M |
| 450 | SNSE | Sensei Biotherapeutics, Inc. | 31.85M | -8.69% | 22,960 | - |
| 451 | SKYE | Skye Bioscience, Inc. | 31.55M | 5.58% | 185,937 | - |
| 452 | IGC | IGC Pharma, Inc. | 31.53M | 0.28% | 291,655 | 1.11M |
| 453 | TVGN | Tevogen Bio Holdings Inc. | 31.15M | 5.80% | 7,531 | - |
| 454 | QNTM | Quantum BioPharma Ltd. | 31.02M | -5.11% | 183,099 | - |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 31.00M | -2.33% | 48,069 | - |
| 456 | SNTI | Senti Biosciences Holdings, Inc. | 30.68M | 1.41% | 156,013 | 22.00K |
| 457 | NNVC | NanoViricides, Inc. | 30.66M | -2.74% | 107,213 | - |
| 458 | HOWL | Werewolf Therapeutics, Inc. | 30.13M | -4.64% | 219,309 | 1.14M |
| 459 | BCTX | BriaCell Therapeutics Corp. | 29.97M | -1.20% | 98,267 | - |
| 460 | LSTA | Lisata Therapeutics, Inc. | 29.17M | -0.92% | 52,693 | 170.00K |
| 461 | KYNB | Kyntra Bio, Inc. | 28.74M | -0.28% | 5,380 | 6.44M |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 28.60M | -1.39% | 22,220 | 14.99M |
| 463 | TPST | Tempest Therapeutics, Inc. | 28.26M | -2.48% | 76,366 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 27.37M | 1.90% | 10,650 | 14.97M |
| 465 | ABVC | ABVC BioPharma, Inc. | 27.18M | - | 20,376 | 797.92K |
| 466 | DYAI | Dyadic International, Inc. | 27.15M | -1.99% | 9,731 | 3.09M |
| 467 | SER | Serina Therapeutics, Inc. | 26.97M | -1.09% | 16,863 | 130.00K |
| 468 | PLRZ | Polyrizon Ltd. | 26.47M | -1.36% | 16,107 | - |
| 469 | CELU | Celularity Inc. | 26.17M | -2.42% | 67,510 | 26.55M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 25.43M | -4.06% | 154,727 | - |
| 471 | LGVN | Longeveron Inc. | 24.94M | -2.54% | 201,888 | 1.20M |
| 472 | MRKR | Marker Therapeutics, Inc. | 24.34M | - | 60,760 | 3.55M |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 23.25M | -3.88% | 317,573 | 789.00K |
| 474 | ALLR | Allarity Therapeutics, Inc. | 23.19M | 1.35% | 229,129 | 320.00K |
| 475 | CRIS | Curis, Inc. | 23.07M | -6.45% | 113,131 | 9.44M |
| 476 | AEON | AEON Biopharma, Inc. | 23.03M | 0.50% | 23,955 | - |
| 477 | OSRH | OSR Holdings, Inc. | 22.89M | 18.34% | 4,124,376 | 2.91M |
| 478 | LTRN | Lantern Pharma Inc. | 22.87M | -4.67% | 104,236 | - |
| 479 | OTLK | Outlook Therapeutics, Inc. | 22.57M | -6.95% | 7,191,809 | 205.70K |
| 480 | VYNE | VYNE Therapeutics Inc. | 22.44M | 0.58% | 227,568 | 570.00K |
| 481 | XCUR | Exicure, Inc. | 21.35M | -1.18% | 2,851 | 500.00K |
| 482 | QNCX | Quince Therapeutics, Inc. | 21.19M | 6.56% | 899,443 | - |
| 483 | KTTA | Pasithea Therapeutics Corp. | 20.95M | -1.16% | 121,079 | - |
| 484 | ICU | SeaStar Medical Holding Corporation | 19.43M | -0.21% | 80,520 | 1.23M |
| 485 | COCP | Cocrystal Pharma, Inc. | 19.37M | -0.35% | 103,463 | - |
| 486 | LPCN | Lipocine Inc. | 19.18M | -1.65% | 50,392 | 1.98M |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 18.53M | -2.43% | 55,426 | - |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 17.73M | -1.85% | 630,101 | 3.94M |
| 489 | GRDX | GridAI Technologies Corp. | 17.67M | 11.33% | 247,056 | - |
| 490 | TRAW | Traws Pharma, Inc. | 17.27M | - | 139,110 | 2.79M |
| 491 | TOVX | Theriva Biologics, Inc. | 16.52M | -5.76% | 763,083 | 300.00K |
| 492 | LEXX | Lexaria Bioscience Corp. | 15.88M | -5.00% | 250,778 | 368.00K |
| 493 | INAB | IN8bio, Inc. | 15.76M | 1.27% | 45,539 | - |
| 494 | BLRX | BioLineRx Ltd. | 15.25M | -7.46% | 13,535 | 1.18M |
| 495 | GNTA | Genenta Science S.p.A. | 15.10M | -7.20% | 65,392 | - |
| 496 | NCEL | NewcelX Ltd. | 14.77M | -2.41% | 7,250 | - |
| 497 | HIND | Vyome Holdings, Inc. | 14.74M | -4.55% | 6,116 | 319.71K |
| 498 | CLRB | Cellectar Biosciences, Inc. | 13.99M | -6.52% | 275,609 | - |
| 499 | PBM | Psyence Biomedical Ltd. | 13.81M | 1.52% | 104,822 | - |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 13.31M | -2.78% | 86,662 | 2.07M |